The biology of breast carcinoma.

Nancy E Davidson, Judith Clancy Keen

Journal: Cancer 2003;97(3 Suppl):825-33

PMID: 12548582

Abstract

The biology of breast carcinoma is complex, with multiple factors contributing to its development and progression. The current review focuses on the role of several critical genes including estrogen receptor, progesterone receptor, retinoic acid receptor-beta, epidermal growth factor receptor family members, p53, BRCA1, and BRCA2 as risk factors for the development of disease, predictors of prognosis and response to therapy, and as therapeutic targets. Studies of the biology of these and other genes that contribute to the development and progression of breast carcinoma have had and will continue to have great impact on all aspects of disease management.

Address: The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland 21231, USA.

DOI: 10.1002/cncr.11126

Link outs

Free resources

Full Text Sources:

https://onlinelibrary.wiley.com/doi/10.1002/cncr.1...

Medical:

https://medlineplus.gov/breastcancer.html

Other Literature Sources:

https://www.lens.org/lens/search/patent/list?q=ref...

Miscellaneous:

https://assays.cancer.gov/CPTAC-3279

Research Materials:

https://antibodies.cancer.gov/detail/CPTC-EGFR-8

MeSH Terms: Biomarkers, Tumor, Breast Neoplasms, Female, Genes, BRCA1, Genes, BRCA2, Genes, p53, Humans, Receptors, Peptide, Receptors, Retinoic Acid, Receptors, Steroid, Risk Factors